1. 2 3. RESEARCH RESULTS. Roche Bioscience shall, in accordance with its established practice, keep complete, accurate and authentic accounts, notes, data and records of the Research performed under this Agreement. Roche Bioscience shall promptly and...Transfer and Research Agreement • October 11th, 1996 • Alanex Corp • Services-commercial physical & biological research • California
EXPLANATORY NOTE: [***] INDICATES THE PORTION OF THIS EXHIBIT THAT HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL ANDTransfer and Research Agreement • August 14th, 2020 • AIM ImmunoTech Inc. • Biological products, (no disgnostic substances) • New York
This Agreement is made as of June 22, 2020 (“Effective Date”) by and between AIM IMMUNOTECH INC. (“AIM”), a corporation incorporated under the laws of Delaware, having an Offices at 2117 SW Hwy 484 Ocala Fl 34473 as the supplier of the experimental drug Ampligen® and a collaborative group consisting of Japanese National Institute of Infectious Disease (“NIID”) with its address at 4-7-1 Gakuen, Musashimurayama-shi, Tokyo, 208-0011 Japan, and Shionogi & Co., Ltd. (including its affiliates, “Shionogi”) with its address at 1-8, Doshomachi 3-chome Chuo-ku, Osaka 541-0045 Japan (together referred to as the “Companies”). AIM, Shionogi and NIID shall be referred to individually as a “Party” and together as the “Parties.”
